Hyuncheol Jung, PhD Postdoctoral Scholar, UCSF-Gladstone Institute of Genomic Immunology Biography Hyuncheol Jung, PhD, is a postdoctoral scholar at the UCSF-Gladstone Institute of Genomic Immunology, jointly mentored by Drs. Julia Carnevale and Alex Marson. His research focuses on cancer immunotherapy and the engineering of human immune cells using CRISPR/Cas9 technologies. Dr. Jung earned his PhD in Biological Sciences from the Korea Advanced Institute of Science and Technology (KAIST), where he developed a novel chimeric fusion protein, αAβ–Gas6, designed to enhance the clearance of amyloid-β plaques in Alzheimer’s disease models. This innovative approach demonstrated effective plaque removal with reduced neuroinflammation and neurotoxicity in preclinical studies. Currently, at UCSF and Gladstone, Dr. Jung is leveraging CRISPR-based screening techniques in monocytes and macrophages to identify critical genes involved in the tumor microenvironment. His work aims to advance the development of more effective cell therapies for cancer patients. Dr. Jung is also a recipient of a postdoctoral fellowship from the National Research Foundation of Korea, supporting his ongoing research endeavors.